Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / COM
-
Shares outstanding
-
66,399,673
-
Total 13F shares
-
59,485,390
-
Share change
-
+13,507,691
-
Total reported value
-
$1,445,333,394
-
Put/Call ratio
-
44%
-
Price per share
-
$24.50
-
Number of holders
-
96
-
Value change
-
+$425,331,067
-
Number of buys
-
68
-
Number of sells
-
37
Institutional Holders of RHYTHM PHARMACEUTICALS, INC. - COM (RYTM) as of Q3 2022
As of 30 Sep 2022,
RHYTHM PHARMACEUTICALS, INC. - COM (RYTM) was held by
96 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
59,485,390 shares.
The largest 10 holders included
PRIMECAP MANAGEMENT CO/CA/, FEDERATED HERMES, INC., BAKER BROS. ADVISORS LP, RA CAPITAL MANAGEMENT, L.P., NEA Management Company, LLC, GOLDMAN SACHS GROUP INC, BlackRock Inc., STATE STREET CORP, VANGUARD GROUP INC, and Frazier Life Sciences Management, L.P..
This page lists
98
institutional shareholders reporting positions in this security
for the Q3 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.